Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck dB Cash Flow — Operating Cash Flow ($M) ($M)
Postgres DB financial_values (via lib/db.py)
Latest, FY2025
16,472
Period ended Dec 31, 2025
Change on a year earlier
-23.3%
21,468 in FY2024
History
19 years
Since FY2007
Sources
12
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | DB Cash Flow — Operating Cash Flow ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 16,472 | -23.3% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 21,468 | +65.1% | Form 10-K (filed 2025-02-25) ↗ |
| FY2023 | Dec 31, 2023 | 13,006 | -31.9% | Form 10-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 19,095 | +45.5% | Form 10-K (filed 2023-02-24) ↗ |
| FY2021 | Dec 31, 2021 | 13,122 | +72.3% | Form 10-K (filed 2022-02-25) ↗ |
| FY2020 | Dec 31, 2020 | 7,617 | -14.3% | Form 10-K (filed 2022-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 8,884 | -18.7% | Form 10-K (filed 2022-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 10,922 | +69.3% | Form 10-K (filed 2019-02-27) ↗ |
| FY2017 | Dec 31, 2017 | 6,451 | -37.8% | Form 10-K (filed 2019-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 10,376 | -17.2% | SEC Filing ↗ |
| FY2015 | Dec 31, 2015 | 12,538 | +56.9% | SEC Filing ↗ |
| FY2014 | Dec 31, 2014 | 7,989 | -31.4% | SEC Filing ↗ |
| FY2013 | Dec 31, 2013 | 11,654 | +16.3% | Form 10-K (filed 2014-02-27) ↗ |
| FY2012 | Dec 31, 2012 | 10,022 | -19.1% | Form 10-K (filed 2013-02-28) ↗ |
| FY2011 | Dec 31, 2011 | 12,383 | +14.4% | Form 10-K (filed 2012-02-28) ↗ |
| FY2010 | Dec 31, 2010 | 10,822 | +219.0% | Form 10-K (filed 2011-02-28) ↗ |
| FY2009 | Dec 31, 2009 | 3,392 | -48.4% | Form 10-K (filed 2010-03-01) ↗ |
| FY2008 | Dec 31, 2008 | 6,572 | -6.1% | Form 10-K (filed 2011-02-28) ↗ |
| FY2007 | Dec 31, 2007 | 6,999 | – | Form 10-K (filed 2010-03-01) ↗ |
Breakdown
What makes up db cash flow — operating cash flow ($m)
- Capital Expenditures ($M)4,112 · FY2025
- Depreciation and Amortization ($M)3,000 · FY2025
- Stock-Based Compensation ($M)820 · FY2025
- Deferred Income Taxes ($M)-1,671 · FY2025
- Change in Accounts Receivable ($M)-1,090 · FY2025
- Change in Inventories ($M)-1,180 · FY2025
- Change in Trade Accounts Payable ($M)110 · FY2025
- Acquisitions of Businesses, Net of Cash Acquired ($M)-10,042 · FY2025
- Purchases of Securities and Other Investments ($M)-1,207 · FY2025
- Net Cash Used in Investing Activities ($M)-13,741 · FY2025
- Proceeds from Issuance of Debt ($M)13,880 · FY2025
- Payments on Debt ($M)-2,503 · FY2025
- Dividends Paid to Stockholders ($M)-8,176 · FY2025
- Purchases of Treasury Stock ($M)-5,084 · FY2025
- Net Cash Used in Financing Activities ($M)-1,922 · FY2025
- Effect of Exchange Rate Changes on Cash ($M)563 · FY2025
- Net Increase (Decrease) in Cash and Cash Equivalents ($M)1,372 · FY2025
- Cash Paid for Interest ($M)1,300 · FY2025
- Cash Paid for Income Taxes ($M)6,086 · FY2025
Cite this data
StockData. (2026). Merck DB Cash Flow — Operating Cash Flow ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_cf_ocf
See every metric in the Merck KPI table. Data updated Oct 26, 2026.